Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 1.6B | 1.6B | 1.5B |
Cost of revenue | 160M | 154M | 147M | 140M |
Gross profit | 1.5B | 1.5B | 1.4B | 1.4B |
Operating expense | ||||
Research & development | 394M | 393M | 378M | 368M |
Selling general and admin | 728M | 699M | 686M | 641M |
Other operating expenses | — | — | — | — |
Operating income | 338M | 381M | 346M | 343M |
Non operating interest income | ||||
Income | — | — | — | 11M |
Expense | 2M | — | — | — |
Other income expense | -102M | -13M | -3M | -2M |
Pretax income | 234M | 372M | 351M | 352M |
Tax provision | 82M | 69M | 76M | 70M |
Net income | 152M | 303M | 275M | 282M |
Basic EPS | 0.7 | — | 1.3 | 1.3 |
Diluted EPS | 0.7 | — | 1.3 | 1.3 |
Basic average shares | 214M | — | 215M | 216M |
Diluted average shares | 216M | — | 217M | 217M |
EBITDA | 387M | 440M | 397M | 393M |
Net income from continuing op. | 152M | 303M | 275M | 282M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |